Key Points There wasn't any news from Zomedica to serve as a catalyst. Today's gain appears to be continued momentum related to an SEC filing made earlier this week by Morgan Stanley. What happened ...
网页链接Key Points There wasn't any news from Zomedica to serve as a catalyst. Today's gain appears to be continued momentum related to an SEC filing made earlier this week by Morgan Stanley. What happened ...
网页链接
精彩评论